In this work, we prepared a novel biocompatible nanoparticle CuS@BSA-NB2 which had two functions: targeting cancer cells with high expression of HER2 protein, and killing breast cancer by photothermal effect (Figure 1). This evidence concerns the gene ERBB2 and breast carcinoma.